Nuo Therapeutics received the full $325,000 second funding commitment on October 6, 2026, bringing total borrowings to $2 million. The company issued secured promissory notes bearing 12% annual interest due December 31, 2028, with interest payable in warrants. Warrants were issued to assuming lenders for the assigned portion of the commitment.
